Drugs / DAAOI-P
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04470037 | Apr 2016 → Dec 2024 | Parkinson disease | China Medical University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DAAOI-P | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04470037 ↗ |
| Action | Inhibit | “DAAOI-P is a D-amino acid oxidase (DAAO) inhibitor” NCT04470037 ↗ |